5,7-Dichlorokynurenic acid, a potent and selective competitive antagonist of the glycine site on NMDA receptors

Neurosci Lett. 1990 Nov 27;120(1):17-20. doi: 10.1016/0304-3940(90)90157-5.

Abstract

Fourteen substituted derivatives of kynurenic acid were compared for their ability to block ionic currents evoked by N-methyl-D-aspartate (NMDA) plus glycine, or kainate, in voltage-clamped Xenopus oocytes injected with rat brain messenger RNA. Among these analogues there was an excellent correlation between the Ki for displacing [3H]glycine binding to rat brain membranes, and the ability to inhibit ionic currents evoked by glycine/NMDA in Xenopus oocytes. In the oocyte 5,7-dichlorokynurenic acid (5,7-DCK) was a competitive blocker of the glycine recognition site on NMDA receptors, and was more potent (KB 65 nM in Schild analysis) and selective (509-fold more potent vs glycine than kainate) than the prototype glycine antagonist, 7-chlorokynurenic acid, 5,7-DCK also reduced NMDA-induced neuron injury in rat cortical cell cultures.

MeSH terms

  • Animals
  • Binding, Competitive
  • Brain / metabolism
  • Evoked Potentials / drug effects
  • Female
  • Glycine / metabolism*
  • Glycine / pharmacology
  • Kinetics
  • Kynurenic Acid / analogs & derivatives*
  • Kynurenic Acid / pharmacology*
  • N-Methylaspartate / pharmacology
  • Oocytes / drug effects
  • Oocytes / physiology*
  • RNA, Messenger / administration & dosage
  • RNA, Messenger / genetics
  • Rats
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / genetics
  • Receptors, N-Methyl-D-Aspartate / physiology*
  • Structure-Activity Relationship
  • Xenopus

Substances

  • RNA, Messenger
  • Receptors, N-Methyl-D-Aspartate
  • N-Methylaspartate
  • Kynurenic Acid
  • 5,7-dichlorokynurenic acid
  • Glycine